Skip to main content
Log in

Ring appearance on Tc-99m MIBI thoracic SPECTs and increased uptake on Tc-99m HMDP thoracic SPECTs in a pulmonary mass of small cell carcinoma

  • Case Report
  • Published:
Annals of Nuclear Medicine Aims and scope Submit manuscript

Abstract

Tc-99m MIBI is taken up avidly by viable tumor tissue and does not accumulate in the necrotic carcinoma. We present a patient who underwent Tc-99m MIBI and Tc-99m HMDP thoracic SPECTs: a large area of increased MIBI uptake with central photopenia (ring appearance) in the right upper lung localizes bone imaging agent and does not localize multiple areas of intense uptake in the metastatic hilar mediastinum lymph nodes. Rapid growth of tumor cells in the lung leading to central necrosis/ischemia accounts for bone imaging agent localization in the tumor, as well as the ring-appearance of lung mass on Tc-99m MIBI imaging. These findings may reflect less viability of the lung tumor as compared with intense MIBI uptake in hilar/mediastinal lymph node uptake without bone agent localization.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Sinusas AJ, Watson DD, Cannon JM, Beller GA. Effect of ischemia and postischemic dysfunction on myocardial up-take of technetium-99m labelled methoxyisobutyl isonitrile and thallium-201.J Am Cardiol 14: 1785–1793, 1989.

    Article  CAS  Google Scholar 

  2. Aktolun C, Bayhan H, Kir M, et al. Clinical experience with Tc-99m MIBI imaging in patients with malignant tumors: preliminary results and comparison with Tl-201.Clin Nucl Med 11: 171–176, 1992.

    Google Scholar 

  3. Hassan IM, Sahweil A, Constantinides C, et al. Uptake and kinetics of Tc-99m hexakis 2-methoxy isobutyl isonitrile in benign and malignant lesions in the lungs.Clin Nucl Med 14: 333–340, 1989.

    Article  PubMed  CAS  Google Scholar 

  4. Lu G, Shih WJ, Xiu JY. Tc-99m MIBI uptake in a parathyroid carcinoma and Brown tumor.J Nucl Med 36: 811–813, 1995.

    PubMed  CAS  Google Scholar 

  5. O’Tuama LA, Packard AB, Treves ST. SPECT imaging of pediatric brain tumor with hexakis (methoxy isobutyl isonitrile) technetium (I).J Nucl Med 31: 2040–2041, 1990.

    PubMed  Google Scholar 

  6. Caner B, Kitapci M, Aras T, Erbengi G, Ugur O, Bekdik C. Increased accumulation of hexakis (2-methoxyisobutylisonitrile) technetium (1).in osteosarcoma and its metastatic lymph nodes.J Nucl Med 32: 1977–1978, 1991.

    PubMed  CAS  Google Scholar 

  7. Caner B, Kitapci M, Unlu M, et al. Technetium-99m MIBI uptake in benign and malignant bone lesions: a comparative study with technetium-99m MDP.J Nucl Med 33: 319–324, 1992.

    PubMed  CAS  Google Scholar 

  8. Waxman AD, Ramanna L, Memsic LD, et al. Thallium scintigraphy in evaluation of mass abdominal abnormalities of the breast.J Nucl Med 34: 19–23, 1993.

    Google Scholar 

  9. Mueller SP, Piotrowski B, Guth-Tougelides B, Reiners C. Tc-99m MIBI and Tl-201 uptake in thyroid carcinoma (abstract).J Nucl Med 29: 854, 1988.

    Google Scholar 

  10. O’Driscoll CM, Baker F, Casey MJ, Duffy GJ. Localization of recurrent medullary thyroid carcinoma with technetium-99m-methoxyisobutylnitrile scintigraphy: a case report.J Nucl Med 32: 2281–2283, 1991.

    PubMed  Google Scholar 

  11. Al-Sebaie S, Rush C. Liver metastases detected by Tc-99m sestamibi during routine cardiac imaging.Clin Nucl Med 20: 84–85, 1995.

    Article  PubMed  CAS  Google Scholar 

  12. Crane P, Laliberte R, Heminway S, Thoolen M, Orlandi C. Effect of mitochondrial viability and metabolism on technetium-99m sestamibi myocardial retention.Eur J Nucl Med 20: 20–25, 1993.

    Article  PubMed  CAS  Google Scholar 

  13. Sinusas AJ, Truatman KA, Bergin JD, Watson DD, Smith WH, Beller G. Quantification of area of risk during coronary occlusion and degree of myocardial salvage after reperfusion with technetium-99m 2-methoxyisobutyl isonitrile.Circulation 82: 1424–1437, 1990.

    PubMed  CAS  Google Scholar 

  14. Beenlands RSB, Dawood F, Wen WH. Are the kinets of technetium 99m methoxyisobutyl isonitrile affected by cell metabolism and viability?Circulation 82: 1802–1814, 1990.

    Google Scholar 

  15. Freeman I, Gruwald AM, Hoory S, Bodenheimer MM. Effect of coronary occlusion and myocardial viability on myocardial activity of Tc-99m sestamibi.J Nucl Med 32: 292–298, 1991.

    PubMed  CAS  Google Scholar 

  16. Bayhan H, Aktolun C, Kir KM, et al. Tc-99m MIBI imaging in patients with intrathoracic malignant tumors (abstract).Eur J Nucl Med 18: 675, 1991.

    Google Scholar 

  17. Aktolun C, Bayhan H, Kir MK, Bilgic H. Evaluation of Tc-99m MIBI for localizing untreated primary lung carcinoma: A clinical study (abstract).Nucl Med Commun 13: 249, 1992.

    Article  Google Scholar 

  18. Aktolun C, Bayhan H, Pabuccu Y, Bilgic H, Acar H, Kaylu R. Assessment of tumor necrosis and detection of mediastinal lymph node metastasis in bronchial carcinoma with Tc-99m sestamibi imaging: comparison with CT scan.Eur J Nucl Med 21: 973–979, 1994.

    PubMed  CAS  Google Scholar 

  19. Shih WJ, Domstad PA, Lieber A, DeLand FH, Coupai JJ. Localization of Tc-99m HMDP in hepatic metastases from chorionic carcinoma.AJR 146: 333–336, 1986.

    PubMed  CAS  Google Scholar 

  20. Que L, Wiseman J, Hales B. Small cell carcinoma of the lung: primary site and hepatic metastases both detected on Tc-99m pyrophosphate bone scan.Clin Nucl Med 6: 260–262, 1980.

    Article  Google Scholar 

  21. Lowenthal IS, Tow DE, Chang YC. Accumulation of Tc-99m polyphosphate in two squamous cell carcinomas of thelung.J Nucl Med 16: 1021–1032, 1975.

    PubMed  CAS  Google Scholar 

  22. Poulose KD, Reba RC, Eckelman WC, Goodyear M. Extraosseous localization of Tc-99m Sn pyrophosphate.Br J Radiol 48: 724–726, 1975.

    Article  PubMed  CAS  Google Scholar 

  23. Heisel AM, Miller JH, Reid BS, Siegel SE. Radionuclide bone scan in neuroblastoma.Pediatrics 71: 206–209, 1983.

    PubMed  CAS  Google Scholar 

  24. Stone CK, Sisson JC. What causes uptake of Tc-99m methylene diphosphonate by tumors? A case where tumor appeared to secrete a hypercalcemia-causing substance.J Nucl Med 26: 250–253, 1985.

    PubMed  CAS  Google Scholar 

  25. Baumert JE, Lanteri RL, Horning S, et al. Liver metastases of breast carcinoma detected on99mTc-methylene diphosphonate.AJR 134: 389–391, 1980.

    PubMed  CAS  Google Scholar 

  26. Balachandran S. Localization of Tc-99m-Sn-pyrophosphate in liver metastasis from carcinoma of colon.Clin Nucl Med 1: 165–166, 1976.

    Article  Google Scholar 

  27. Garcia AC, Yeh SDJ, Benau RS. Accumulation of bone seeking radionuclides in the liver metastasis from colon carcinoma.Clin Nucl Med 2: 265–269, 1977.

    Article  Google Scholar 

  28. Stevens JS, Clark EE. Liver metastasis of colon adenocarcinoma demonstrated on Tc-99m pyrophosphate bone scan.Clin Nucl Med 2: 270–271, 1977.

    Article  Google Scholar 

  29. Shih WJ, Coupai J. Diffuse and intense Tc-99m HMDP localization in the liver due to hypoxia secondary to respiratory failure.Clin Nucl Med 19: 116–120, 1994.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shih, WJ., Turturro, F., Stipp, V. et al. Ring appearance on Tc-99m MIBI thoracic SPECTs and increased uptake on Tc-99m HMDP thoracic SPECTs in a pulmonary mass of small cell carcinoma. Ann Nucl Med 10, 425–428 (1996). https://doi.org/10.1007/BF03164804

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03164804

Key words

Navigation